MLchartDataset catalogue

nilotinib

Term · Oncology and biomedicine · MLC-T-ONC-005834

A drug used to treat certain types of chronic myelogenous leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Nilotinib blocks BCR::ABL1 and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called Tasigna.

Table 1. Record
IdentifierMLC-T-ONC-005834
FieldOncology and biomedicine
SynonymsTasigna
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005834",
  "term": "nilotinib",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat certain types of chronic myelogenous leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Nilotinib blocks BCR::ABL1 and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called Tasigna.",
  "synonyms": [
    "Tasigna"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/nilotinib/"
}

Record 11,832 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.